Premium
Anastrozole is superior to tamoxifen as first‐line therapy in hormone receptor–positive advanced breast carcinoma
Author(s) -
Gluck Stefan
Publication year - 2002
Publication title -
cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.052
H-Index - 304
eISSN - 1097-0142
pISSN - 0008-543X
DOI - 10.1002/cncr.10962
Subject(s) - anastrozole , tamoxifen , medicine , oncology , retrospective cohort study , clinical trial , subgroup analysis , gynecology , breast cancer , cancer , meta analysis